NXT BIOMEDICAL, LLC — Form D/A
NXT BIOMEDICAL, LLC of IRVINE, CA, a company, filed a Form D amendment with the SEC on 2021-05-25. The offering totals $9.4M, of which $9.4M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-05-25
- Form: D/A
- Accession: 0001862731-21-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $9.4M
- Amount sold: $9.4M
- Investors: 2
- Date of first sale: 2020-07-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-400576
Issuer
- Name: NXT BIOMEDICAL, LLC
- CIK: 0001862731
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Address: 5171 CALIFORNIA AVENUE, SUITE 150, IRVINE, CA, 92617
- Phone: 201.658.6455
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Andrew ElBardissi | Director | St. Louis Park, MN |
| Stanton Rowe | Director | Los Angeles, CA |
| Stanton Rowe | Executive Officer | Los Angeles, CA |
| Kadhiresan V Kadir | Director | Irvine, CA |
| Andrew V Cleeland | Director | Irvine, CA |
| Don Bobo | Director | Irvine, CA |
| Steven V Hochberg | Director | Irvine, CA |
Other filings by this issuer (2)
More